The global Inherited Retinal Diseases (Irds) Market is undergoing a profound transformation. Characterized by a genetically diverse group of rare genetic eye disorders that lead to progressive vision loss, IRDs have historically had limited therapeutic options. However, recent leaps in genomic medicine, molecular diagnostics, and targeted therapies are rapidly altering the patient car... https://www.databridgemarketresearch.com/